CLINICAL_TRIALS
trial_result
· 2013-09-26
Clinical Trial Update: Biological Markers of Response to Treatment in Major Depressive Disorder [Phase 3]
Summary
A Phase 3 clinical trial investigates biological markers associated with treatment response in Major Depressive Disorder, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2013-09-26